Search Results - t-cell+reprogramming

1 Results

Sort By:

Novel Immunotherapy for Cancer Treatment: Chimeric Antigen Receptors Targeting CD70 Antigen

Abstract: Scientists at the NCI's Surgery Branch have developed anti-CD70 chimeric antigen receptors (CARs) to treat cancers. CD70 is an antigen that is expressed on a variety of human cancers such as renal cell carcinoma, glioblastoma, non-Hodgkin's lymphoma, and chronic lymphocytic leukemia. The anti-CD70 CARs are hybrid proteins consisting of a receptor...

Published: 4/8/2024 | Inventor(s): Qiong Wang, Zhiya Yu, James Yang

Keywords(s): CARS, CD70, chimeric antigen receptor, T-cell reprogramming

Category(s): TherapeuticArea > Oncology, Application > Therapeutics, Collaboration Sought > Licensing